Targeting EGFR allosteric site with marine-natural products of Clathria Sp.: A computational approach-Reference-Cited by-同舟云学术

Targeting EGFR allosteric site with marine-natural products of Clathria Sp.: A computational approach

Published:2024 Issue: Volume:7 Page:100125
ISSN:2665-928X
Container-title:Current Research in Structural Biology
language:en
Short-container-title:Current Research in Structural Biology

Author:

Nurisyah ,Ramadhan Dwi Syah Fitra^ORCID,Dewi Ratnasari,asikin Asyhari,Daswi Dwi Rachmawaty,adam Adriyani,Chaerunnimah ,Sunarto ,Rafika ,Artati ,Fakih Taufik Muhammad

Publisher

Elsevier BV

Reference22 articles.

1. KNApSAcK family databases: integrated metabolite-plant species databases for multifaceted plant research;Afendi;Plant Cell Physiol.,2012

2. DockRMSD: an open-source tool for atom mapping and RMSD calculation of symmetric molecules through graph isomorphism;Bell;J. Cheminf.,2019

3. Third-generation EGFR and ALK inhibitors: mechanisms of resistance and management;Cooper;Nat. Rev. Clin. Oncol.,2022

4. EGFR mutation mediates resistance to EGFR tyrosine kinase inhibitors in NSCLC: from molecular mechanisms to clinical research;Dong;Pharmacol. Res.,2021

5. Afatinib for the treatment of EGFR mutation-positive NSCLC: a review of clinical findings;Harvey;J. Oncol. Pharm. Pract. : official publication of the International Society of Oncology Pharmacy Practitioners,2020

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Computational quest to inhibit enoyl-acyl carrier protein reductase (InhA) enzyme in Mycobacterium tuberculosis from Lannea coromandelica (Houtt.) Merr. metabolite via molecular docking and dynamics;Pharmacia;2024-08-02

2. Anticancer activity of Araguspongine C via inducing apoptosis, and inhibition of oxidative stress, inflammation, and EGFR‐TK in human lung cancer cells: An in vitro and in vivo study;Journal of Biochemical and Molecular Toxicology;2024-07

3. Molecular docking-based virtual screening and computational investigations of biomolecules (curcumin analogs) as potential lead inhibitors for SARS-CoV-2 papain-like protease;Pharmacia;2024-06-25